Digital Breast Tomosynthesis (DBT) Market Size, Share, Scope Report 2026 to 2035
What is Digital Breast Tomosynthesis (DBT) Market Size?
Global Digital Breast Tomosynthesis (DBT) Market Size is valued at USD 899.05 Mn in 2025 and is predicted to reach USD 1,250.42 Mn by the year 2035 at a 10.7% CAGR during the forecast period for 2026 to 2035.
Digital Breast Tomosynthesis (DBT) Market Size, Share & Trends Analysis Distribution by Product Type (2D/3D Combination Systems, Standalone 3D Systems, Upgrade / Retrofit Kits), By Component (Hardware, Software, Services), By End User (Hospitals, Diagnostic Imaging Centres, Breast Cancer Screening Centres / Clinics, Academic & Research Institutions) and Segment Forecasts, 2026 to 2035.
-Market--Size.webp "Digital Breast Tomosynthesis (DBT) Market Size")
Digital breast tomosynthesis (DBT), also known as 3D mammography, is a new form of mammography that uses low-dose X-rays taken from various angles around the breast and reconstructed into a three-dimensional image of the breast. While conventional two-dimensional mammography shows a flattened X-ray picture of the breast, 3D mammography offers radiologists an opportunity to scan through layers of breast tissue. 3D mammography represents a major breakthrough in the field of breast cancer detection and diagnosis since it improves lesions' detectability and decision-making processes for patients with dense breasts.
Breast cancer continues to be one of the leading cancers that affect women around the globe, which increases the necessity of having efficient methods of early diagnosis. Modern medical professionals tend to use highly sophisticated technologies in the process of conducting screenings to ensure accuracy and avoid false positives. Digital Breast Tomosynthesis is becoming an essential part of any breast imaging protocol, as this method can be used in combination with traditional mammography and other diagnostic tools. The continuous development in technology improves the efficiency of using DBT.
The market for digital breast tomosynthesis (DBT) technology has received significant momentum owing to the global emphasis being laid by the healthcare industry on improving capabilities for the detection of cancers in patients. Investment in the diagnostic imaging industry, increased awareness regarding breast health, and an increase in the organized screening programs have contributed significantly towards the adoption of the DBT technology in the hospitals, diagnostic imaging centers, and breast care centers.
Competitive Landscape
Which are the Leading Players in the Digital Breast Tomosynthesis (DBT) Market?
- Allengers
- Canon
- DMS Group
- FUJIFILM Corporation
- GE HealthCare
- Genoray Co., Ltd
- General Medical Merate S.p.A.
- Hologic, Inc.
- Metaltronica S.p.A.
- Mecanmedical
- Planmed Oy
- Siemens Healthineers
- Shanghai United Imaging Healthcare Co., LTD
Market Dynamics
Driver
Increasing Focus on Early and Accurate Breast Cancer Detection
One of the factors driving growth in the digital breast tomosynthesis market is the increasing focus on early and accurate detection of breast cancer. With the increased prevalence of breast cancer across the globe, healthcare organizations have increasingly begun using advanced technologies to increase the effectiveness and efficiency of diagnostic procedures while reducing the drawbacks of traditional 2D mammography. The ability of DBT technology to create 3-D images of breasts, improve the rate of cancer detection, and avoid false positive calls has been one reason why DBT has become a popular diagnostic technique.
Restrain/Challenge
High Equipment Costs and Limited Accessibility
One of the major challenges facing the DBT market is that of the huge costs incurred in purchasing, installation, and maintenance of DBT machines. The technology is capital intensive and thus difficult to adopt by smaller health care centers, which lack the requisite capital investment and technical infrastructure. In addition, poor or lack of insurance cover and differences in the health care infrastructure in some regions make DBT inaccessible to some parts of the world, especially in the developing countries.
2D/3D Combination Systems Segment is Expected to Drive the Digital Breast Tomosynthesis (DBT) Market
The 2D/3D combination systems category is dominating the digital breast tomosynthesis (DBT) market owing to their capacity to provide conventional 2D mammography along with 3D imaging of the breast. These systems provide more clinical versatility because it allows healthcare facilities to conduct routine screening and diagnostic procedures using one system only. The systems' compatibility with current work procedures, ease of use, and improved diagnostic precision make them the ideal solution for healthcare facilities. Due to the rising need for comprehensive breast imaging systems from healthcare facilities, the demand for 2D/3D combination systems is increasing.
Software Segment is Growing at the Highest Rate in the Digital Breast Tomosynthesis (DBT) Market
Software is anticipated to witness the highest growth rate in the digital breast tomosynthesis (DBT) market because of the rise in demand for image processing solutions, AI-driven diagnostic devices, and workflow solutions. With the objective of improving the accuracy of diagnosis and decreasing the burden on radiologists, more funds are being invested in software platforms supporting image reconstruction and computer-aided diagnosis and data management solutions. Moreover, the increasing deployment of AI and machine learning technologies in breast imaging systems is driving the adoption of software solutions, which will make software the fastest-growing component segment.
Why North America Led the Digital Breast Tomosynthesis (DBT) Market?
The North American region is at the forefront of the digital breast tomosynthesis (DBT) market, owing to its well-developed healthcare system, high acceptance of advanced breast imaging modalities, and the use of breast cancer screening programs. Some factors driving the development in the
-Market-Region.webp "Digital Breast Tomosynthesis (DBT) Market Region")
North American region include good awareness about the early detection of breast cancer, positive reimbursement scenario, and considerable investments in diagnostic imaging devices. Furthermore, the presence of key medical imaging players, technological developments, and regulatory approval are some of the factors fueling the adoption of DBT in the region.
Key Development
• In March 2025, GE HealthCare launched Invenia ABUS Premium, an AI-enabled 3D breast ultrasound system designed to improve supplemental screening for women with dense breasts. The solution enhances image quality, streamlines exam interpretation, and supports earlier cancer detection by improving the sensitivity of breast cancer screening when used alongside mammography.
Digital Breast Tomosynthesis (DBT) Market Report Scope:
| Report Attribute | Specifications |
| Market size value in 2025 | USD 899.05 Mn |
| Revenue forecast in 2035 | USD 1,250.42 Mn |
| Growth Rate CAGR | CAGR of 10.7% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Product Type, Component, End-User and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | Hologic, Inc., Siemens Healthineers AG, GE HealthCare Technologies, Fujifilm Holdings Corporation, Koninklijke Philips N.V., Canon Medical Systems Corporation, Planmed Oy, IMS Giotto S.r.l., Konica Minolta, Inc., Shimadzu Corporation |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentations Digital Breast Tomosynthesis (DBT) Market:
Digital Breast Tomosynthesis (DBT) Market by Product Type -
- 2D/3D Combination Systems
- Standalone 3D Systems
- Upgrade / Retrofit Kits
-Market-Seg.webp "Digital Breast Tomosynthesis (DBT) Market Segmentations")
Digital Breast Tomosynthesis (DBT) Market by Component -
- Hardware
- Software
- Services
Digital Breast Tomosynthesis (DBT) Market by End User-
- Hospitals
- Diagnostic Imaging Centres
- Breast Cancer Screening Centres / Clinics
- Academic & Research Institutions
Digital Breast Tomosynthesis (DBT) Market by Region-
- North America-
- The US
- Canada
- Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East and Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
- North America-
- The US
- Canada
- Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East and Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Digital Breast Tomosynthesis (DBT) Market Size is valued at USD 899.05 Mn in 2025 and is predicted to reach USD 1,250.42 Mn by the year 2035
The Digital Breast Tomosynthesis (DBT) Market is expected to grow at a 10.7% CAGR during the forecast period for 2026 to 2035
Hologic, Inc., Siemens Healthineers AG, GE HealthCare Technologies, Fujifilm Holdings Corporation, Koninklijke Philips N.V., Canon Medical Systems Corporation, Planmed Oy, IMS Giotto S.r.l., Konica Minolta, Inc., Shimadzu Corporation and Others.
Digital Breast Tomosynthesis (DBT) Market is segmented into Product Type, Component, End-User and Other.
North America region is leading the Digital Breast Tomosynthesis (DBT) Market